• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞通讯的拦截模式

Intercepting Modes of Cellular Communication.

作者信息

Claflin Kristin E, Potthoff Matthew J

机构信息

Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, Iowa; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, Iowa; Iowa Neuroscience Institute, University of Iowa Carver College of Medicine, Iowa City, Iowa.

Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma; Department of Biochemistry and Physiology, University of Oklahoma Health Sciences, Oklahoma City, Oklahoma; Harold Hamm Diabetes Center, University of Oklahoma Health Sciences, Oklahoma City, Oklahoma.

出版信息

Cell Mol Gastroenterol Hepatol. 2025 May 8;19(8):101531. doi: 10.1016/j.jcmgh.2025.101531.

DOI:10.1016/j.jcmgh.2025.101531
PMID:40348018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12209953/
Abstract

Metabolic homeostasis is maintained through a delicate balance of communication within and between multiple organ systems. These communication networks are essential for regulating nutrient intake, utilization, and storage. Conditions of metabolic dysfunction can impair proper tissue communication, which contributes to the progression of metabolic disease including obesity, hepatic steatosis, and type II diabetes. In this collection of Cellular and Molecular Gastroenterology and Hepatology, we highlight new advances in transcellular and interorgan communication, particularly in the liver and gastrointestinal (GI) tract, and how impairments in these biologic networks contribute to metabolic disease. In addition, we emphasize the therapeutic potential for modulating these communication pathways to treat metabolic disease.

摘要

代谢稳态通过多个器官系统内部以及它们之间精细的沟通平衡得以维持。这些沟通网络对于调节营养物质的摄入、利用和储存至关重要。代谢功能障碍的情况会损害正常的组织间沟通,进而促使包括肥胖、肝脂肪变性和II型糖尿病在内的代谢性疾病的发展。在这本《细胞与分子胃肠病学和肝病学》论文集中,我们重点介绍了跨细胞和器官间沟通方面的新进展,特别是在肝脏和胃肠道方面,以及这些生物网络中的损伤如何导致代谢性疾病。此外,我们强调了调节这些沟通途径以治疗代谢性疾病的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2592/12209953/e34f788fcbbf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2592/12209953/e34f788fcbbf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2592/12209953/e34f788fcbbf/gr1.jpg

相似文献

1
Intercepting Modes of Cellular Communication.细胞通讯的拦截模式
Cell Mol Gastroenterol Hepatol. 2025 May 8;19(8):101531. doi: 10.1016/j.jcmgh.2025.101531.
2
Interorgan and Transcellular Communication in Metabolic Disease: Insights From Recent CMGH Studies.代谢性疾病中的器官间和跨细胞通讯:CMGH近期研究的见解
Cell Mol Gastroenterol Hepatol. 2025 May 8;19(8):101530. doi: 10.1016/j.jcmgh.2025.101530.
3
Short-Term Memory Impairment短期记忆障碍
4
Exercise, the Gut Microbiome and Gastrointestinal Diseases: Therapeutic Impact and Molecular Mechanisms.运动、肠道微生物群与胃肠道疾病:治疗作用及分子机制
Gastroenterology. 2025 Feb 17. doi: 10.1053/j.gastro.2025.01.224.
5
Inappropriate Diet Exacerbates Metabolic Dysfunction-Associated Steatotic Liver Disease via Abdominal Obesity.不当饮食通过腹部肥胖加剧代谢功能障碍相关脂肪性肝病。
Nutrients. 2024 Dec 5;16(23):4208. doi: 10.3390/nu16234208.
6
Study on the modulation of kidney and liver function of rats with diabetic nephropathy by Huidouba through metabolomics.回豆巴通过代谢组学对糖尿病肾病大鼠肝肾功 能的调节作用研究
J Ethnopharmacol. 2025 Jun 11;351:120136. doi: 10.1016/j.jep.2025.120136.
7
The Midlands Liver Research Alliance - A partnership to optimise obesity-related liver disease research: targeting areas of high incidence and underserved communities.中部地区肝脏研究联盟——优化肥胖相关肝病研究的合作伙伴关系:针对高发病地区和服务不足的社区。
NIHR Open Res. 2024 Dec 12;4:75. doi: 10.3310/nihropenres.13784.1. eCollection 2024.
8
Genetic depletion of adipose-derived Isthmin-1 causes hepatic steatosis.脂肪组织来源的伊斯汀-1基因缺失导致肝脂肪变性。
Mol Metab. 2025 May 26;98:102172. doi: 10.1016/j.molmet.2025.102172.
9
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
10
The health economics of insulin therapy: How do we address the rising demands, costs, inequalities and barriers to achieving optimal outcomes.胰岛素治疗的卫生经济学:我们如何应对不断增长的需求、成本、不平等现象以及实现最佳治疗效果的障碍。
Diabetes Obes Metab. 2025 Jul;27 Suppl 5(Suppl 5):24-35. doi: 10.1111/dom.16488. Epub 2025 Jun 4.

引用本文的文献

1
Transcellular, Interorgan, and Host-microbial Communication in Metabolic Homeostasis: Hearing for the First Time What We Once Thought to be Unspoken.代谢稳态中的跨细胞、器官间及宿主-微生物通讯:首次听到我们曾以为无法言说之事。
Cell Mol Gastroenterol Hepatol. 2025 Jun 9;19(9):101545. doi: 10.1016/j.jcmgh.2025.101545.

本文引用的文献

1
On the causes of obesity and its treatment: The end of the beginning.论肥胖的成因及其治疗:开端的结束。
Cell Metab. 2025 Mar 4;37(3):570-577. doi: 10.1016/j.cmet.2025.01.026.
2
Metabolic Messengers: small extracellular vesicles.代谢信使:小细胞外囊泡
Nat Metab. 2025 Feb;7(2):253-262. doi: 10.1038/s42255-024-01214-5. Epub 2025 Feb 7.
3
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH).代谢功能障碍相关脂肪性肝炎(MASH)的治疗前景
Nat Rev Drug Discov. 2025 Mar;24(3):171-189. doi: 10.1038/s41573-024-01084-2. Epub 2024 Nov 28.
4
Intestinal Stearoyl-CoA Desaturase-1 Regulates Energy Balance via Alterations in Bile Acid Homeostasis.肠酰基辅酶 A 去饱和酶 1 通过改变胆汁酸稳态调节能量平衡。
Cell Mol Gastroenterol Hepatol. 2024;18(6):101403. doi: 10.1016/j.jcmgh.2024.101403. Epub 2024 Sep 14.
5
Hepatocellular RECK as a Critical Regulator of Metabolic Dysfunction-associated Steatohepatitis Development.肝细胞 REck 作为代谢功能障碍相关脂肪性肝炎发展的关键调节因子。
Cell Mol Gastroenterol Hepatol. 2024;18(3):101365. doi: 10.1016/j.jcmgh.2024.101365. Epub 2024 May 24.
6
Resmetirom: First Approval.雷美替胺:首次获批
Drugs. 2024 Jun;84(6):729-735. doi: 10.1007/s40265-024-02045-0. Epub 2024 May 21.
7
New and emerging treatments for metabolic dysfunction-associated steatohepatitis.代谢功能障碍相关脂肪性肝炎的新型及新兴治疗方法。
Cell Metab. 2024 Jun 4;36(6):1430. doi: 10.1016/j.cmet.2024.04.016. Epub 2024 Apr 25.
8
Endothelial Slc35a1 Deficiency Causes Loss of LSEC Identity and Exacerbates Neonatal Lipid Deposition in the Liver in Mice.内皮细胞 Slc35a1 缺乏导致小鼠肝脏中 LSEC 特征丧失,并加剧新生儿期脂质沉积。
Cell Mol Gastroenterol Hepatol. 2024;17(6):1039-1061. doi: 10.1016/j.jcmgh.2024.03.002. Epub 2024 Mar 11.
9
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study.在一项随机2期研究中,efruxifermin联合GLP-1受体激动剂治疗非酒精性脂肪性肝炎/代谢相关脂肪性肝病和2型糖尿病患者的安全性和有效性
Clin Gastroenterol Hepatol. 2025 Jan;23(1):103-113. doi: 10.1016/j.cgh.2024.02.022. Epub 2024 Mar 4.
10
Current status and future perspectives of FGF21 analogues in clinical trials.在临床试验中 FGF21 类似物的现状和未来展望。
Trends Endocrinol Metab. 2024 May;35(5):371-384. doi: 10.1016/j.tem.2024.02.001. Epub 2024 Feb 28.